SCHEMBL14017686

SCHEMBL14017686

C[Si](C)(C)COC(=O)/C(C#N)=C\C=C(c1ccccc1)c1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.41
TP53 P04637 1/20 0.41
TDP1 Q9NUW8 2/20 0.40
POLB P06746 2/20 0.40
ALDH1A1 P00352 10/20 0.39
DHODH Q02127 1/20 0.39
MAOB P27338 2/20 0.38
KMT2A Q03164 7/20 0.38
MEN1 O00255 4/20 0.38
HPGD P15428 1/20 0.38
MAPK1 P28482 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
SMN1; SMN2 Q16637 5/20 0.38
NPC1 O15118 4/20 0.38
RAB9A P51151 4/20 0.38
NPSR1 Q6W5P4 2/20 0.38
STAT1 P42224 1/20 0.37
KDM4E B2RXH2 1/20 0.37
PKM P14618 1/20 0.37
ATM Q13315 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14017685 0.87 MAOB (0.40) MAPTTP53TDP1POLBALDH1A1
SCHEMBL14017688 0.85 DNM1 (0.39) MAPTTP53TDP1POLBALDH1A1
SCHEMBL17466006 0.85 MAPT (0.52) MAPTTP53TDP1POLBALDH1A1
SCHEMBL14163400 0.85 DNM1 (0.46) MAPTTP53TDP1POLBALDH1A1
SCHEMBL14017683 0.82 KMT2A (0.41) MAPTTDP1POLBALDH1A1KMT2A
SCHEMBL14486187 0.81 MTNR1A (0.39) MAPTTDP1POLBALDH1A1KMT2A
SCHEMBL1576724 0.80 POLB (0.46) MAPTTDP1POLBALDH1A1KMT2A
SCHEMBL1576722 0.80 POLB (0.46) MAPTTDP1POLBALDH1A1KMT2A
SCHEMBL4851098 0.79 DNM1 (0.37) MAPTTP53TDP1POLBALDH1A1
SCHEMBL14018853 0.79 ALDH1A1 (0.36) MAPTTP53TDP1POLBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7432386-B2 Diarylbutadiene-substituted methyltrialkylsilanes and photoprotective compositions comprised thereof L'OREAL (FR) 2008-10-07 US disclosed
US-20070213547-A1 For UV-photoprotecting human skin against the damaging effects of UV-radiation, notably UV-A radiation; example: monotrimethylsilanylmethyl monoethyl diester of (3,3-diphenyl-2-propylidene)propanedioic acid; good resistance to water and to perspiration L'OREAL 2007-09-13 US disclosed
US-7229609-B2 Diarylbutadiene-substituted methyltrialkylsilanes and photoprotective compositions comprised thereof L'OREAL (FR) 2007-06-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070213547-A1 For UV-photoprotecting human skin against the damaging effects of UV-radiation, notably UV-A radiation; example: monotrimethylsilanylmethyl monoethyl diester of (3,3-diphenyl-2-propylidene)propanedioic acid; good resistance to water and to perspiration CUTA, DDB1, DCLRE1A MAPT 2214/4885TP53 545/4885TDP1 1260/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.